Feasibility of CALM in Patients With Ovarian Cancer
Recruiting now NCT06459271
Run by University Health Network, Toronto · for 18 and older · Women
What this study is about
The goal of this feasibility trial is to determine the feasibility and acceptability of implementing a brief evidence-based psychotherapeutic intervention, Managing Cancer And Living Meaningfully (CALM), at the time of a new diagnosis and recurrence of ovarian cancer (OC). The main questions are: 1. Is it feasible and acceptable to implement CALM for patients with newly diagnosed or recently recurred advanced OC 2. What is the patient experience of CALM-TF at new diagnosis or recurrence Participants will be asked to complete questionnaires at baseline and at 3 and 6 months following a diagnosis or recurrence of stage III or IV OC. Participants will also be invited to participate in 3-6 sessions of CALM therapy.
Who can join (things the study team will check)
✅ You may be able to join if…
- new diagnosis or recurrence of stage III or stage IV OC;
- age ≥18 years
- able to complete outcome measures and engage in CALM in English.
🚫 You may not be able to join if…
- evidence of cognitive impairment indicated in the medical record, communicated by the OC clinic team, or determined by research staff at recruitment;
- receiving psychological or psychiatric counseling from the Department of Supportive Care at PM at the time of recruitment.
Where this trial is running
- Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Who to contact
Megan A George, BSc · 6475463114 · megan.george@uhn.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT06459271.
Verify everything on the official ClinicalTrials.gov record. Page updated September 2026.